RPL7L1P2

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RPL7L1P2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL7L1P2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL7L1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL7L1P2 is over-expressed in tumor.

STAD and LIHC are the cancer types where RPL7L1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7L1P2 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
STADFemaleIII,IV+0.114.0015view →
LIHCAllAll+0.013.0102view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL7L1P2–STAD

Tumor-vs-normal expression box plot for RPL7L1P2 RNA in STAD.

Open the STAD breakdown →

Exploration